Medication assessment tool to detect care issues from routine data: a pilot study in primary care
- 20 August 2013
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 35 (6) , 1063-1074
Abstract
Background Medication assessment tools (MATs) may be implemented in routine electronic data sources in order to identify patients with opportunities for optimisation of medication therapy management (MTM) and follow-up by a multi-disciplinary team. Objective (1) To demonstrate the use of a MAT for cardiovascular conditions (MATCVC) as a means of profiling potential opportunities for MTM optimisation in primary care and (2) to assess the performance of MATCVC in identifying actual opportunities for better care. Setting Members of a pharmacotherapy discussion group, i.e. two single-handed general practitioners (GPs), three GP partners, and community pharmacists (CPs) from each of two community pharmacies, in a rural part of the Netherlands. Methods MATCVC comprises 21 medication assessment criteria, each of which is designed to detect a specific care issue and to check whether it is ‘addressed’ by provision of guideline recommended care or ‘open’ in the presence (‘open explained’) or absence (‘open unexplained’) of pre-specified explanations for guideline deviations. (1) Relevant data was extracted from linked GP and CP electronic records and MATCVC assessment was conducted to profile the population of CVC patients registered with both, participating CPs and GPs, in terms of ‘open unexplained’ care issues. (2) A purposive sample of patients with ‘open unexplained’ care issues was reviewed by each patient’s GP. Main outcome measures Number and proportion of ‘open unexplained’ care issues per MATCVC criterion and per patient. The number of patients with MATCVC detected ‘open unexplained’ care issues to be reviewed (NNR) in order to identify one that requires changes in MTM. Results In 1,876 target group patients, MATCVC identified 6,915 care issues, of which 2,770 (40.1 %) were ‘open unexplained’. At population level, ten MATCVC criteria had particularly high potential for quality improvement. At patient level, 1,277 (68.1 %) target group patients had at least one ‘open unexplained’ care issue. For patients with four or more ‘open unexplained’ care issues, the NNR was 2 (95 % CI 2–2). Conclusion The study demonstrates potential ways of using MATCVC as a key component of a collaborative MTM system. Strategies that promote documentation and sharing of explanations for deviating from guideline recommendations may enhance the utility of the approach.Keywords
This publication has 48 references indexed in Scilit:
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvementBMC Clinical Pharmacology, 2012
- Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findingsBritish Journal of General Practice, 2010
- Differential Impact of NSAIDs on Rate of Adverse Events that Require Hospitalization in High-Risk and General Veteran PopulationsDrugs & Aging, 2010
- GP-support by means of AGnES-practice assistants and the use of telecare devices in a sparsely populated region in Northern Germany – proof of conceptBMC Family Practice, 2009
- Adherence to Medication Guideline Criteria in Cancer Pain ManagementJournal of Pain and Symptom Management, 2009
- Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort studyEuropean Journal of Epidemiology, 2009
- The Potential and Pitfalls of Medicine ManagementDisease Management and Health Outcomes, 2008
- Does pharmacist‐led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta‐analysisBritish Journal of Clinical Pharmacology, 2007
- Reasons for Not Intensifying Medications: Differentiating “Clinical Inertia” from Appropriate CareJournal of General Internal Medicine, 2007